Full Text View
Tabular View
No Study Results Posted
Related Studies
A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
This study has been completed.
Study NCT00269399   Information provided by Salix Pharmaceuticals
First Received: December 22, 2005   Last Updated: April 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Clostridium Infections
Diarrhea
Additional conditions recognized in this trial
Infection
More general conditions related to this trial
Bacterial Infections
Gram-Positive Bacterial Infections
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
Rifaximin (Xifaxan)
Additional drug interventions recognized in this trial
Rifaximin
Vancomycin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Salix Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services